A UPMC pulmonologist discusses RSV, including what the symptoms are, who is most at risk and how effective the vaccine is.

Pfizer is looking to follow its vaccine/oral antiviral combination that has proved so profitable in COVID-19 with a similar approach in respiratory syncytial virus (RSV).

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

Approximately 1 in 20 adults with outpatient respiratory syncytial virus (RSV) infections were readmitted to the hospital within 28 days, based on new data from more than 67,000 cases. RSV remains ...

Through the project, Vu aims to understand how RSV, a common infant lung infection, influences long-term respiratory health. Vu and his team hope to discover new therapies that could stop the ...

Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton notes.

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s Enflonsia.

COVID-19, the flu and RSV share many symptoms and may be challenging to distinguish from one another. "Flu symptoms often include high fever, cough, sore throat, congestion, muscle aches and fatigue.